Semaglutide vs SLU-PP-332

Name: Semaglutide vs SLU-PP-332
Published: 2026-10-24

Updated Oct 24, 20268 sources

Key differences

1Semaglutide is an approved GLP-1 drug that works by cutting appetite. SLU-PP-332 raised energy use and fat burning in mice with no change in food intake.
2Semaglutide has large human trials; SLU-PP-332 has none.

Facts from each record, in the same words as their own pages.

Semaglutide and SLU-PP-332 side by side
	Semaglutide	SLU-PP-332
Category	GLP-1, Weight loss	Weight loss, Longevity
Evidence	Strong human trials	Animal data only
FDA status	FDA approved as Ozempic +2Regulatory	Not FDA approvedRegulatory
WADA	Not prohibited	Not confirmed
Half-life	About 1 week. It is still present 5 to 7 weeks after the last dose.Regulatory	No half-life published in any species. After a 30 mg/kg injection in mice it was still measurable in plasma and muscle 2 to 6 hours later.Clinical study One guide states about 1.5 hours in mice, without citing a study.Competitor guide
Routes	Subcutaneous injection, Oral	Subcutaneous injection, Oral
Forms	Not reported	Vial (powder), Tablet, Capsule, Oral solution
Reported doses	0.125 to 7.2 mg (subcutaneous injection) 1.5 to 25 mg (oral) 300 to 1,000 mcg (subcutaneous injection)	250 to 1,500 mcg (subcutaneous injection) 1 to 10 mg (subcutaneous injection) 5 to 100 mg (oral)
Most cited frequency	Once weekly; 4 weeks per step, then hold at 2.4 mg	Once daily; 500 mcg a day is a common example
Vial sizes	5 mg, 10 mg, 20 mg, 30 mgVendor guide	5 mg, 10 mg, 20 mgVendor guide
Mixed vial keeps	Keep the mixed vial in the fridge and use it within about 28 days; one guide says 30.Competitor guide	Fridge at 2 to 8 °C, protected from light.Competitor guide
Protocols on file	12	7

Doses shown are what sources report, labelled by origin. Not medical advice.

8 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.